The partnership will integrate PhaseV's adaptive clinical trial technology with Alimentiv's comprehensive GI CRO services.
Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology ...
The research aims to enhance patient-specific treatment plans, improve outcomes, reduce trial-and-error in medication, and foster a more efficient, personalised healthcare approach ...
For people living with Type 1 Diabetes, keeping blood sugar levels in check is a constant challenge. A new clinical trial at ...
PhaseV's Adaptive Clinical Trials Platform Will Support the Gastrointestinal CRO in Addressing a Wide Range of GI-Related Conditions The collaboration has the potential to accelerate the ...
Hip fractures in older adults can lead to serious complications, disability and even death. Traditionally, orthopaedic ...
A new $10.8 million multicenter clinical trial co-led by Gerard Slobogean, MD, MPH, an Associate Professor of Orthopaedics ...